Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization

被引：0
|
作者：
Anna C. F. Lewis
Emma F. Perez
Anya E. R. Prince
Hana R. Flaxman
Lizbeth Gomez
Deanna G. Brockman
Paulette D. Chandler
Benjamin J. Kerman
Matthew S. Lebo
Jordan W. Smoller
Scott T. Weiss
Carrie L. Blout Zawatksy
James B. Meigs
Robert C. Green
Jason L. Vassy
Elizabeth W. Karlson
机构：
[1] Harvard University,E.J. Safra Center for Ethics
[2] Brigham and Women’s Hospital,Department of Medicine
[3] Mass General Brigham Personalized Medicine,College of Law
[4] University of Iowa,Department of Pathology
[5] Weill Cornell Medical College,undefined
[6] Color Health,undefined
[7] Brigham and Women’s Hospital,undefined
[8] Harvard Medical School,undefined
[9] Program in Medical and Population Genetics,undefined
[10] Broad Institute of MIT and Harvard,undefined
[11] Center for Genomic Medicine,undefined
[12] Massachusetts General Hospital,undefined
[13] Center for Precision Psychiatry,undefined
[14] Massachusetts General Hospital,undefined
[15] Stanley Center for Psychiatric Research,undefined
[16] Broad Institute of MIT and Harvard,undefined
[17] Channing Division of Network Medicine,undefined
[18] Population Precision Health,undefined
[19] Ariadne Labs,undefined
[20] The MGH Institute of Health Professions,undefined
[21] Division of General Internal Medicine,undefined
[22] Massachusetts General Hospital,undefined
[23] Mass General Brigham Personalized Medicine,undefined
[24] Veterans Affairs Boston Healthcare System,undefined
[25] Division of General Internal Medicine and Primary Care,undefined
[26] Brigham and Women’s Hospital,undefined
来源：
Genome Medicine | / 14卷
关键词：
Polygenic risk scores; Report design; Preventative medicine; Personalized medicine; Qualitative semi-structured interviews;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization
    Lewis, Anna C. F.
    Perez, Emma F.
    Prince, Anya E. R.
    Flaxman, Hana R.
    Gomez, Lizbeth
    Brockman, Deanna G.
    Chandler, Paulette D.
    Kerman, Benjamin J.
    Lebo, Matthew S.
    Smoller, Jordan W.
    Weiss, Scott T.
    Zawatksy, Carrie L. Blout
    Meigs, James B.
    Green, Robert C.
    Vassy, Jason L.
    Karlson, Elizabeth W.
    [J]. GENOME MEDICINE, 2022, 14 (01)
  • [2] Development of a clinical assay for reporting polygenic risk scores
    Lebo, Matthew
    Hao, Limin
    Berriz, Gabriel
    Danowski, Morgan
    Koch, Christopher
    Kumar, Prathik Korategere
    Lewis, Anna
    Parpattedar, Shruti
    Steeves, Marcie
    Yu, Wanfeng
    Kraft, Peter
    Vassy, Jason
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S217 - S217
  • [3] Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk Clinical Perspectives and Basic Implications
    Aragam, Krishna G.
    Natarajan, Pradeep
    [J]. CIRCULATION RESEARCH, 2020, 126 (09) : 1159 - 1177
  • [4] Potential use of clinical polygenic risk scores in psychiatry - ethical implications and communicating high polygenic risk
    Palk, A. C.
    Dalvie, S.
    de Vries, J.
    Martin, A. R.
    Stein, D. J.
    [J]. PHILOSOPHY ETHICS AND HUMANITIES IN MEDICINE, 2019, 14 (1)
  • [5] Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk
    A. C. Palk
    S. Dalvie
    J. de Vries
    A. R. Martin
    D. J. Stein
    [J]. Philosophy, Ethics, and Humanities in Medicine, 14
  • [6] Clinical Implications of Integrating Polygenic Risk Into Established Cardiovascular Disease Risk Scores
    Riveros-Mckay, Fernando
    Selzam, Saskia
    Seth, Priyanka
    Moore, Rachel
    Tarran, William A.
    O'Sullivan, Jack W.
    Ashley, Euan A.
    McVean, Gilean
    Plagnol, Vincent
    Donnelly, Peter
    Weale, Michael E.
    [J]. CIRCULATION, 2021, 144
  • [7] On the utilization of polygenic risk scores for therapeutic targeting
    Gibson, Greg
    [J]. PLOS GENETICS, 2019, 15 (04):
  • [8] Binary vs. continuous: understanding provider and patient preference for polygenic risk score reporting
    Lewis, Anna
    Perez, Emma
    Prince, Anya
    Vassy, Jason
    Flaxman, Hana
    Gomez, Lizbeth
    Zawatsky, Carrie Blout
    Brockman, Deanna
    Meigs, James
    Kerman, Benjamin
    Lebo, Matthew
    Chandler, Paulette
    Weiss, Scott
    Smoller, Jordan
    Green, Robert
    Karlson, Elizabeth
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S292 - S293
  • [9] Implementation and implications for polygenic risk scores in healthcare
    John L. Slunecka
    Matthijs D. van der Zee
    Jeffrey J. Beck
    Brandon N. Johnson
    Casey T. Finnicum
    René Pool
    Jouke-Jan Hottenga
    Eco J. C. de Geus
    Erik A. Ehli
    [J]. Human Genomics, 15
  • [10] Implementation and implications for polygenic risk scores in healthcare
    Slunecka, John L.
    van der Zee, Matthijs D.
    Beck, Jeffrey J.
    Johnson, Brandon N.
    Finnicum, Casey T.
    Pool, Rene
    Hottenga, Jouke-Jan
    de Geus, Eco J. C.
    Ehli, Erik A.
    [J]. HUMAN GENOMICS, 2021, 15 (01)
12345